Every CVE Search/ Get API key

CVE-2023-33364

An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows...

8.8 High

An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows authenticated users to execute arbitrary OS commands on the BioStar 2 server.

Attack profile

How easy it is to exploit

Attack vector
Network
Complexity
Low
Privileges needed
Low
User interaction
None

What an attacker can affect

Confidentiality
High
Integrity
High
Availability
High

Exploit likelihood

1.56%Up 1.5 points since Aug 4, 2023
90%50%10%1%

What each source reports

NVD Score used 8.8

An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows authenticated users to execute arbitrary OS commands on the BioStar 2 server.

Record
CVE-2023-33364
CVSS 3.1
8.8 HighCVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Weakness
CWE-78
Updated
2026-11-02
CVE List No score

An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows authenticated users to execute arbitrary OS commands on the BioStar 2 server.

Record
CVE-2023-33364
Updated
2026-11-02
EUVDEUVD-2023-37527 No score

An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows authenticated users to execute arbitrary OS commands on the BioStar 2 server.

Record
EUVD-2023-37527
Updated
2026-11-03
GitHub AdvisoriesGHSA-wc5r-96vx-4jj6 8.8

An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows...

An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows authenticated users to execute arbitrary OS commands on the BioStar 2 server.

Record
GHSA-wc5r-96vx-4jj6
CVSS 3.1
8.8 HighCVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Weakness
CWE-78
Updated
2026-11-02

Affected products

History

History
RecordedChangedSources
aliasesEUVD
first indexedCVE List, GitHub Advisories, NVD

Dates are when Every CVE recorded each change. Upstream dates may differ.

In short

CVE-2023-33364 is a high vulnerability (CVSS 8.8) in Supremainc Biostar 2, published August 3, 2023. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.56%, the 75th percentile. No source names a fixed version.

References

MoveEnter Open